108 related articles for article (PubMed ID: 32557523)
1. Phosphorylated TDP-43 localizes to chronic cerebral infarctions in human brains.
Umahara T; Uchihara T; Hirao K; Shimizu S; Hanyu H
Histol Histopathol; 2020 Sep; 35(9):1023-1028. PubMed ID: 32557523
[TBL] [Abstract][Full Text] [Related]
2. Frontotemporal dementia-associated protein "phosphorylated TDP-43" localizes to atherosclerotic lesions of human carotid and main cerebral arteries.
Umahara T; Uchihara T; Hirao K; Shimizu S; Hashimoto T; Akimoto J; Kohno M; Hanyu H
Histol Histopathol; 2020 Feb; 35(2):159-167. PubMed ID: 31259382
[TBL] [Abstract][Full Text] [Related]
3. Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration.
Yousef A; Robinson JL; Irwin DJ; Byrne MD; Kwong LK; Lee EB; Xu Y; Xie SX; Rennert L; Suh E; Van Deerlin VM; Grossman M; Lee VM; Trojanowski JQ
Acta Neuropathol Commun; 2017 Sep; 5(1):68. PubMed ID: 28877758
[TBL] [Abstract][Full Text] [Related]
4. The phosphatase calcineurin regulates pathological TDP-43 phosphorylation.
Liachko NF; Saxton AD; McMillan PJ; Strovas TJ; Currey HN; Taylor LM; Wheeler JM; Oblak AL; Ghetti B; Montine TJ; Keene CD; Raskind MA; Bird TD; Kraemer BC
Acta Neuropathol; 2016 Oct; 132(4):545-61. PubMed ID: 27473149
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models.
Coudert L; Nonaka T; Bernard E; Hasegawa M; Schaeffer L; Leblanc P
Cell Mol Life Sci; 2019 Jul; 76(13):2615-2632. PubMed ID: 30863908
[TBL] [Abstract][Full Text] [Related]
6. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration--immunohistochemical and biochemical analyses of TDP-43.
Kosaka T; Fu YJ; Shiga A; Ishidaira H; Tan CF; Tani T; Koike R; Onodera O; Nishizawa M; Kakita A; Takahashi H
Neuropathology; 2012 Aug; 32(4):373-84. PubMed ID: 22098653
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes.
Takeuchi R; Tada M; Shiga A; Toyoshima Y; Konno T; Sato T; Nozaki H; Kato T; Horie M; Shimizu H; Takebayashi H; Onodera O; Nishizawa M; Kakita A; Takahashi H
Acta Neuropathol Commun; 2016 Jun; 4(1):61. PubMed ID: 27338935
[TBL] [Abstract][Full Text] [Related]
8. Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes.
Neumann M; Frick P; Paron F; Kosten J; Buratti E; Mackenzie IR
Acta Neuropathol; 2020 Nov; 140(5):645-658. PubMed ID: 32778941
[TBL] [Abstract][Full Text] [Related]
9. Comparison of phosphorylated TDP-43-positive inclusions in oculomotor neurons in patients with non-ALS and ALS disorders.
Mizuno Y; Fujita Y; Takatama M; Okamoto K
J Neurol Sci; 2012 Apr; 315(1-2):20-5. PubMed ID: 22257502
[TBL] [Abstract][Full Text] [Related]
10. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates.
Laferrière F; Maniecka Z; Pérez-Berlanga M; Hruska-Plochan M; Gilhespy L; Hock EM; Wagner U; Afroz T; Boersema PJ; Barmettler G; Foti SC; Asi YT; Isaacs AM; Al-Amoudi A; Lewis A; Stahlberg H; Ravits J; De Giorgi F; Ichas F; Bezard E; Picotti P; Lashley T; Polymenidou M
Nat Neurosci; 2019 Jan; 22(1):65-77. PubMed ID: 30559480
[TBL] [Abstract][Full Text] [Related]
11. Chronic cerebral ischemia induces redistribution and abnormal phosphorylation of transactivation-responsive DNA-binding protein-43 in mice.
Shindo A; Yata K; Sasaki R; Tomimoto H
Brain Res; 2013 Oct; 1533():131-40. PubMed ID: 23954745
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated TDP-43 Staging of Primary Age-Related Tauopathy.
Zhang X; Sun B; Wang X; Lu H; Shao F; Rozemuller AJM; Liang H; Liu C; Chen J; Huang M; Zhu K
Neurosci Bull; 2019 Apr; 35(2):183-192. PubMed ID: 30382507
[TBL] [Abstract][Full Text] [Related]
13. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
Takeda T
Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions.
Mori F; Tada M; Kon T; Miki Y; Tanji K; Kurotaki H; Tomiyama M; Ishihara T; Onodera O; Kakita A; Wakabayashi K
Acta Neuropathol Commun; 2019 Oct; 7(1):165. PubMed ID: 31661037
[TBL] [Abstract][Full Text] [Related]
15. C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation.
Josephs KA; Zhang YJ; Baker M; Rademakers R; Petrucelli L; Dickson DW
Acta Neuropathol Commun; 2019 Jul; 7(1):100. PubMed ID: 31266542
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
[TBL] [Abstract][Full Text] [Related]
17. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
[TBL] [Abstract][Full Text] [Related]
18. [Neurodegenerative disorders and TDP-43].
Nonaka T; Inukai Y; Arai T; Hasegawa M
Brain Nerve; 2009 Feb; 61(2):161-6. PubMed ID: 19235466
[TBL] [Abstract][Full Text] [Related]
19. Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord.
Braak H; Ludolph A; Thal DR; Del Tredici K
Acta Neuropathol; 2010 Jul; 120(1):67-74. PubMed ID: 20379728
[TBL] [Abstract][Full Text] [Related]
20. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Arai T; Hasegawa M; Akiyama H; Ikeda K; Nonaka T; Mori H; Mann D; Tsuchiya K; Yoshida M; Hashizume Y; Oda T
Biochem Biophys Res Commun; 2006 Dec; 351(3):602-11. PubMed ID: 17084815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
